He maha ngā tūmomo mate urutā manawa i te takurua
Kua whai hua hoki ngā mahi hei whakaiti i te horapa o te SARS-CoV-2 ki te whakaiti i te horapa o ētahi atu huaketo manawa. I te mea he maha ngā whenua e whakaiti ana i te whakamahinga o ēnei mahi, ka horapa tahi te SARS-CoV-2 me ētahi atu huaketo manawa, ka piki ake te tūponotanga o ngā mate pāwera.
E matapaetia ana e ngā tohunga tera pea ka toru ngā mate urutā i tēnei hotoke nā te huinga o ngā tihi o te rewharewha (Rewharewha) me te mate urutā manawa (RSV) me te mate urutā SARS-CoV-2. Kua teitei ake te maha o ngā kēhi o te rewharewha me te RSV i tēnei tau i tērā o taua wā anō i ngā tau o mua. Nā ngā momo hou BA.4 me BA.5 o te huaketo SARS-CoV-2 kua kino ake anō te mate urutā.
I te "Huihuinga mō te Rā Rewharewha o te Ao 2022" i te 1 o Noema, 2022, i tātarihia e Zhong Nanshan, he tohunga mātauranga nō te Chinese Academy of Engineering, te āhua o te rewharewha i te kāinga me tāwāhi, ā, i mahia e ia ngā rangahau me ngā whakatau hou mō te āhua o nāianei."Kei te aro tonu te ao ki te mōrearea o ngā mate urutā e hono tahi ana me te mate urutā SARS-CoV-2 me te mate urutā rewharewha," tana kī, "Ina koa i tēnei hotoke, me whakapakari tonu te rangahau mō ngā take pūtaiao o te aukati me te whakahaere i te rewharewha."E ai ki ngā tatauranga a te US CDC, kua tino piki ake te maha o ngā haerenga ki te hōhipera mō ngā mate manawa i te Hononga o Amerika nā te huinga o te rewharewha me ngā mate pukupuku hou.
Ko te pikinga ake o ngā kitenga RSV me ngā haerenga ki ngā tari whawhati tata me ngā whakaurunga hōhipera e pā ana ki te RSV i roto i ngā rohe maha o te US, me ētahi rohe e tata ana ki ngā taumata tihi o te wā. I tēnei wā, kua eke te maha o ngā keehi mate RSV i te US ki te tihi teitei rawa atu i roto i te 25 tau, ā, kua kī tonu ngā hōhipera tamariki, ā, kua kati ētahi kura.
I pakaru mai te mate urutā rewharewha i Ahitereiria i te marama o Āperira o tēnei tau, ā, tata ki te whā marama te roa. I te 25 o Hepetema, e 224,565 ngā kēhi rewharewha kua whakaūtia e te taiwhanga, ā, e 305 ngā mate e pā ana ki tēnā. He rerekē, i raro i ngā mahi ārai mate urutā SARS-CoV-2, e tata ana ki te 21,000 ngā kēhi rewharewha i Ahitereiria i te tau 2020, ā, iti iho i te 1,000 i te tau 2021.
E whakaatu ana te pūrongo ā-wiki 35 o te China Influenza Center i te tau 2022, kua teitei ake te ōwehenga o ngā mate rewharewha i ngā kawanatanga o te raki i te taumata o taua wā anō i te tau 2019-2021 mō ngā wiki e whā karapīpiti ana, ā, ka nui ake te kino o te āhua o te heke mai. I waenganui o Hune, kua piki ake te maha o ngā mate rewharewha i pūrongohia i Guangzhou mā te 10.38 ngā wā i whakaritea ki tērā tau.
Ko ngā hua o tētahi rangahau tauira whenua 11 i tukuna e The Lancet Global Health i te marama o Oketopa i whakaatu kua piki ake te ngāwari o te taupori o nāianei ki te rewharewha tae atu ki te 60% i whakaritea ki mua i te mate urutā. I matapaetia hoki ka piki ake te kaha o te wā rewharewha o te tau 2022 mā te 1-5 ngā wā, ā, ka piki ake te rahi o te mate urutā tae atu ki te 1-4 ngā wā.
212,466 ngā pakeke kua pangia e te mate SARS-CoV-2 i whakaurua ki te hōhipera. I tuhia ngā whakamātautau mō ngā mate urutā manawa mō ngā tūroro 6,965 kua pangia e te SARS-CoV-2. I kitea te mate urutā i roto i te 583 (8·4%) tūroro: 227 ngā tūroro he huaketo rewharewha, 220 ngā tūroro he huaketo rewharewha syncytial, ā, 136 ngā tūroro he adenovirus.
I honoa te pangia tahi me ngā huaketo rewharewha ki te pikinga ake o te tūponotanga ki te whiwhi i te manawa ā-ringa whakaeke i whakaritea ki te pangia kotahi a te SARS-CoV-2. Ko ngā pangia tahi a te SARS-CoV-2 me ngā huaketo rewharewha me ngā adenovirus he hononga nui ki te pikinga ake o te tūponotanga mate. Ko te OR mō te manawa ā-ringa whakaeke i roto i te pangia tahi a te rewharewha he 4.14 (95% CI 2.00-8.49, p=0.0001). Ko te OR mō te mate i roto i te hōhipera i roto i ngā tūroro pangia tahi a te rewharewha he 2.35 (95% CI 1.07-5.12, p=0.031). Ko te OR mō te mate i roto i te hōhipera i roto i ngā tūroro pangia tahi a te adenovirus he 1.6 (95% CI 1.03-2.44, p=0.033).
E whakaatu mārama ana ngā hua o tēnei rangahau he tino morearea te pangia tahitia o te huaketo SARS-CoV-2 me te huaketo rewharewha.
I mua i te pakarutanga mai o te SARS-CoV-2, he tino ōrite ngā tohu o ngā huaketo manawa rerekē, engari he rerekē ngā tikanga maimoatanga. Ki te kore ngā tūroro e whakawhirinaki ki ngā whakamātautau maha, ka uaua ake te maimoatanga o ngā huaketo manawa, ā, ka tere te moumou rauemi hōhipera i ngā wā e nui ana te mate. Nō reira, he mea nui te mahi a ngā whakamātautau hononga maha i roto i te tautuhi haumanu, ā, ka taea e ngā tākuta te tuku tautuhi rerekē o ngā mate i roto i ngā tūroro he tohu manawa mā te tauira kotahi.
Whakamātautau-Macro me te Micro SARS-CoV-2 Otinga Kimi Hononga Maha
Kei a Macro & Micro-Test ngā tūāpapa hangarau pēnei i te PCR tauanga fluorescent, te whakanui isothermal, te ārai mate, me te POCT ngota, ā, e whakarato ana i ngā momo hua kimi hononga manawa SARS-CoV-2. Kua whiwhi katoa ngā hua i te tiwhikete EU CE, me te mahi hua tino pai me te wheako kaiwhakamahi pai.
1. Kete RT-PCR kanapa wā-tūturu mō te kimi i ngā momo mate manawa e ono
Mana Whakahaere ā-rotoAroturukihia katoatia te tukanga whakamātautau kia pai ai te kounga o ngā whakamātautau.
Teitei o te Whai HuaMā te PCR wā-tūturu maha ka kitea ngā momo pūtau motuhake mō te SARS-CoV-2, te rewharewha A, te rewharewha B, te Adenovirus, te Mycoplasma pneumoniae, me te huaketo Respiratory syncytial.
Te aro nui300 Ngā Tārua/mL mō te SARS-CoV-2, 500 Ngā Tārua/mL mō te huaketo rewharewha A, 500 Ngā Tārua/mL mō te huaketo rewharewha B, 500 Ngā Tārua/mL mō te huaketo syncytial manawa, 500 Ngā Tārua/mL mō te mycoplasma pneumoniae, me te 500 Ngā Tārua/mL mō te adenovirus.
2. Kete Kimi Waikawa Nukleika SARS-CoV-2/Rewharewha A/Rewharewha B (PCR Whakapūmau)
Mana Whakahaere ā-rotoAroturukihia katoatia te tukanga whakamātautau kia pai ai te kounga o ngā whakamātautau.
Teitei o te Whai HuaKa kitea e te PCR wā-tūturu maha ngā momo ūnga rerekē mō te SARS-CoV-2, te rewharewha A me te rewharewha B.
Te aro nui300 Ngā Tārua/mL o te SARS-CoV-2,500 Ngā Tārua/mL o te lFV A me te 500 Ngā Tārua/mL o te lFV B.
3. Kete Kimi Paturopi SARS-CoV-2, Rewharewha A me te Rewharewha B (Immunochromatography)
Ngāwari ki te Whakamahi
Te pāmahana rūma Te kawe me te rokiroki i te 4-30°℃
Teitei o te aro me te motuhaketanga
| Ingoa Hua | Whakatakotoranga |
| Kete RT-PCR kanapa wā-tūturu mō te kimi i ngā momo mate manawa e ono | 20 ngā whakamātautau/kete,48 ngā whakamātautau/kete,50 ngā whakamātautau/kete |
| Kete Kimi Waikawa Matū SARS-CoV-2/Rewharewha A/Rewharewha B (PCR Whakapūmau) | 48 ngā whakamātautau/kete,50 ngā whakamātautau/kete |
| Kete Kimi Paturopi SARS-CoV-2, Rewharewha A me te Rewharewha B (Immunochromatography) | 1 whakamātautau/kete,20 ngā whakamātautau/kete |
Wā tuku: Hakihea-09-2022